NCS Multistage (NCSM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
Achieved strong financial performance in 2025, with revenue up 13% year-over-year to $183.6 million and Q4 revenue of $50.6 million, exceeding guidance and driven by leadership in well construction and completion technologies.
Adjusted EBITDA for 2025 was $26.7 million, up 20% year-over-year, with a margin of 15%.
Integration of ResMetrics enhanced tracer diagnostics capabilities, expanded market reach in the Middle East, and contributed $5.2 million to 2025 services revenue.
Maintained a capital-light, asset-light business model, generating robust free cash flow and supporting strategic acquisitions and organic growth.
Continued investment in technology, operational efficiency, and product innovation, with ongoing cost optimization.
Financial highlights
2025 revenue: $183.6 million, up 13% year-over-year; Q4 revenue: $50.6 million, up 13% year-over-year.
Adjusted EBITDA for 2025: $26.7 million (20% increase), margin 15%; Q4 adjusted EBITDA: $9.2 million, margin over 18%.
Net income for 2025: $23.7 million, or $8.65 per diluted share, including $11.5 million positive tax impact; Q4 net income: $15.0 million, including $9.8 million tax benefit.
Free cash flow after distributions: $18.9 million in 2025, over 70% conversion from adjusted EBITDA.
Cash at year-end: $36.7 million; net cash position: $29.1 million; total liquidity: ~$61 million.
Outlook and guidance
2026 revenue guidance: $184–$194 million; adjusted EBITDA: $26–$29 million; free cash flow after distributions: $12–$16 million.
Q1 2026 revenue expected at $49–$53 million; adjusted gross margin 39–41%; adjusted EBITDA $6.5–$8.5 million.
Revenue growth anticipated in U.S. and international markets, especially the Middle East; Canadian revenue expected to decline due to lower rig count and customer consolidation.
Market environment expected to remain challenging in North America, with international growth weighted to the second half of 2026.
Capital expenditures for 2026 expected at $1.5–$2 million.
Latest events from NCS Multistage
- Q2 2026 revenue rose 5% year-over-year, but net loss widened amid merger and legal costs.NCSM
Q2 202631 Jul 2026 - Record international growth, margin expansion, and profitability highlighted 2024 results.NCSM
Q4 20248 Jul 2026 - Q1 2026 revenue fell 8.7–9%, but U.S. growth and strong 2026 outlook signal resilience.NCSM
Q1 202630 Apr 2026 - Strong technology-driven growth, robust free cash flow, and expanding global market presence.NCSM
Investor presentation30 Apr 2026 - Expanding globally with innovative completions technology and disciplined capital allocation.NCSM
Lytham Partners 2026 Industrials & Basic Materials Summit22 Apr 2026 - Shareholders will vote on directors, auditor ratification, and executive pay, with robust governance in place.NCSM
Proxy filing2 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.NCSM
Proxy filing2 Apr 2026 - Q2 2024 revenue up 17% with improved margins and raised 2024 guidance on strong international growth.NCSM
Q2 20242 Feb 2026 - Q3 2024 revenue up 15% year-over-year, with strong global demand and margin expansion.NCSM
Q3 202417 Jan 2026